Lv5
1310 积分 2024-01-31 加入
Proteomic Signatures for Risk Prediction of Atrial Fibrillation
2个月前
已完结
A Decadal Exploration of Cutaneous Adverse Effects of FDA-Approved Cardiovascular Medications: Insights from 2013 to 2023
2个月前
已完结
Long-term changes in frailty and incident atrial fibrillation, heart failure, coronary heart disease, and stroke: A prospective follow-up study
2个月前
已完结
An update on inclisiran for the treatment of elevated LDL cholesterol
2个月前
已完结
Inclisiran: A Review in Hypercholesterolemia
2个月前
已完结
From clinical development to real-world outcomes with inclisiran
2个月前
已完结
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent
2个月前
已完结
Inclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol
2个月前
已完结
Inclisiran as a siRNA Inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9); Past, Present, and Future
2个月前
已完结
Frailty and Self-Care Maintenance Mediated by Social Support and Depression in Older Adults With Heart Failure
3个月前
已完结
皖公网安备34019202002308
